Empirical Treatment of Highly Suspected Nontuberculous Mycobacteria Infections Following Aesthetic Procedures

Background Infection caused by nontuberculous mycobacteria (NTM) has been increasing. Awareness of this infection is crucial yet problematic. Delayed management may lead to destructive results. We empirically treated a series of patients with clinical suspicion of NTM infection prior to the identification of the pathogen.

Methods A total of 12 patients who developed surgical site infections between January 2011 and February 2014 were reviewed. Patients with a skin and subcutaneous infection resistant to standard management over two weeks, and previous history of aesthetic procedures within three months were regarded as highly suspected of having an NTM infection. A variety of diagnostic modalities were examined simultaneously, along with starting empirical treatment including a combination of clarithromycin and moxifloxacin, and surgical debridement.

Results All wounds healed completely within 4 weeks. The mean follow-up duration was 7.2 months, and none of the patients developed relapse. Specific NTM pathogens were identified in six patients. Eight patients showed caseating granuloma implying an NTM infection. One patient showed an uncommon Stenotrophomonas infection, which was successfully treated. Three patients had no evidence of a pathogen despite repeated microbial tests. Complications such as scarring, pigmentation, and disfigurement were common in all the patients.

Conclusions NTM should be considered in the differential diagnosis of an unusual skin and soft-tissue infection. We propose an empirical regimen of clarithromycin and moxifloxacin as an efficient treatment option for an NTM infection.

Keywords

Mycobacterium infections, nontuberculous - Soft-tissue infections - Early diagnosis - Antibiotics, antitubercular

Publikationsverlauf

Eingereicht: 09. Juni 2014

Angenommen: 17. Juli 2014

Artikel online veröffentlicht:
05. Mai 2022

• References

• 1 Griffith DE, Aksamit T, Brown-Elliott BA. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416
• 2 Lim JM, Kim JH, Yang HJ. Management of infections with rapidly growing mycobacteria after unexpected complications of skin and subcutaneous surgical procedures. Arch Plast Surg 2012; 39: 18-24
• 3 Murillo J, Torres J, Bofill L. et al. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. Arch Dermatol 2000. 136. 1347-1352
• 4 Clegg HW, Foster MT, Sanders Jr WE. et al. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 1983; 147: 427-433
• 5 Meyers H, Brown-Elliott BA, Moore D. et al. An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis 2002; 34: 1500-1507
• 6 Gravante G, Caruso R, Araco A. et al. Infections after plastic procedures: incidences, etiologies, risk factors, and antibiotic prophylaxis. Aesthetic Plast Surg 2008; 32: 243-251
• 7 Hsiao CH, Tsai TF, Hsueh PR. Characteristics of skin and soft tissue infection caused by non-tuberculous mycobacteria in Taiwan. Int J Tuberc Lung Dis 2011; 15: 811-817
• 8 Liao CH, Lai CC, Ding LW. et al. Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis 2007; 11: 96-102
• 9 Macadam SA, Mehling BM, Fanning A. et al. Nontuberculous mycobacterial breast implant infections. Plast Reconstr Surg 2007; 119: 337-344
• 10 Guay DR. Moxifloxacin in the treatment of skin and skin structure infections. Ther Clin Risk Manag 2006; 2: 417-434
• 11 Callender VD, St Surin-Lord S, Davis EC. et al. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol 2011; 12: 87-99
• 12 Elston D. Nontuberculous mycobacterial skin infections: recognition and management. Am J Clin Dermatol 2009; 10: 281-285
• 13 Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996; 23: 146-158
• 14 Yeam YS, Jeong OY, Jang SJ. et al. Comparison of culture, Acid-Fast stain and polymerase chain reaction assay for detection of mycobacterium tuberculosis. Korean J Clin Pathol 1995; 15: 594-603
• 15 Bagyalakshmi R, Senthilvelan B, Therese KL. et al. Application of polymerase chain reaction (PCR) and PCR based restriction fragment length polymorphism for detection and identification of dermatophytes from dermatological specimens. Indian J Dermatol 2008; 53: 15-20
• 16 Molecules and Diagnositcs Incorporation. REBA Myco-ID product manual. Wonju, KR: Molecules and Diagnositcs Incorporation; 2009
• 17 Kim BJ, Lee SH, Lyu MA. et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 1999; 37: 1714-1720
• 18 Hwang S, Oh KJ, Jang IH. et al. Evaluation of the diagnostic performance of the advansure TB/NTM real-time PCR kit for detection of mycobacteria. Korean J Clin Microbiol 2011; 14: 55-59
• 19 Yu JR, Heo ST, Lee KH. et al. Skin and soft tissue infection due to rapidly growing mycobacteria: case series and literature review. Infect Chemother 2013; 45: 85-93
• 20 Dodiuk-Gad R, Dyachenko P, Ziv M. et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57: 413-420
• 21 Gillespie SH, Billington O. Activity of moxifloxacin against mycobacteria. J Antimicrob Chemother 1999; 44: 393-395
• 22 Choi GE, Min KN, Won CJ. et al. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. Antimicrob Agents Chemother 2012; 56: 3549-3555
• 23 Reddy P, Das S, Chandler JP. et al. Stenotrophomonas maltophilia meningitis treated with moxifloxacin: a case report and review of the literature. Infect Dis Clin Prac 2006; 14: 173-176
• 24 Son SW, Kim HJ, Seo JW. A case of Stenotrophomonas maltophilia keratitis effectively treated with moxifloxacin. Korean J Ophthalmol 2011; 25: 349-351